Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

20.35
BATS BZX Real-Time Price
As of 11:14am ET
 -0.45 / -2.16%
Today’s Change
7.20
Today|||52-Week Range
27.09
+105.14%
Year-to-Date

Today’s Trading

Previous close20.80
Today’s open19.70
Day’s range19.40 - 20.37
Volume30,679
Average volume (3 months)927,143
Market cap$986.9M
Dividend yield--
Data as of 11:14am ET, 08/22/2017

Growth & Valuation

Earnings growth (last year)+17.50%
Earnings growth (this year)+15.27%
Earnings growth (next 5 years)+85.00%
Revenue growth (last year)+208.07%
P/E ratioNM
Price/Sales9.64
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AIMTAimmune Therapeutics...+0.05+0.26%
AKCAAkcea Therapeutics I...+0.43+2.85%
ACORAcorda Therapeutics ...+0.42+1.95%
DERMDermira Inc+0.60+2.62%
Data as of 11:14am ET, 08/22/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)-$0.33
Annual revenue (last year)$41.6M
Annual profit (last year)-$66.7M
Net profit margin-160.38%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Gregory A. Demopulos
CFO, Treasurer, Chief Accounting Officer &
VP
Michael A. Jacobsen
Corporate headquarters
Seattle, Washington

Forecasts